Journal of Hematology & Oncology (May 2023)
Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
- Muhammad Elnaggar,
- Sarita Agte,
- Paula Restrepo,
- Meghana Ram,
- David Melnekoff,
- Christos Adamopoulos,
- Mark M. Stevens,
- Katerina Kappes,
- Violetta Leshchenko,
- Daniel Verina,
- Sundar Jagannath,
- Poulikos I. Poulikakos,
- Samir Parekh,
- Alessandro Laganà
Affiliations
- Muhammad Elnaggar
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Sarita Agte
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Paula Restrepo
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Meghana Ram
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- David Melnekoff
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Christos Adamopoulos
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Mark M. Stevens
- Travera
- Katerina Kappes
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Violetta Leshchenko
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Daniel Verina
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Sundar Jagannath
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Poulikos I. Poulikakos
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Samir Parekh
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Alessandro Laganà
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- DOI
- https://doi.org/10.1186/s13045-023-01449-x
- Journal volume & issue
-
Vol. 16,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
